EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Adverse effects of chemotherapy – answers 67<br />
D<br />
A 34-year-old man is referred to radiotherapy with sem<strong>in</strong>oma.<br />
-hCG is also raised <strong>in</strong> choriocarc<strong>in</strong>oma. Unlike teratoma, AFP is not<br />
raised <strong>in</strong> sem<strong>in</strong>oma.<br />
26 Risk factors for malignancy<br />
Answers: K A H C J<br />
K<br />
A<br />
H<br />
C<br />
J<br />
Previous exposure to anil<strong>in</strong>e dyes.<br />
Contact with anil<strong>in</strong>e dyes is associated with bladder cancer.<br />
Epste<strong>in</strong>–Barr virus <strong>in</strong>fection <strong>in</strong> a native African.<br />
Epste<strong>in</strong>–Barr virus <strong>in</strong>fection is a risk factor for Burkitt’s lymphoma, posttransplant<br />
lymphoma and HIV-associated lymphoma.<br />
Coeliac disease.<br />
There is an <strong>in</strong>creased <strong>in</strong>cidence of T-cell lymphoma and adenocarc<strong>in</strong>oma<br />
of the small bowel.<br />
Pernicious anaemia.<br />
Pernicious anaemia is associated with later gastric carc<strong>in</strong>oma.<br />
Unprotected sexual <strong>in</strong>tercourse with several sexual partners.<br />
Transmission of human papilloma virus is believed to be relevant <strong>in</strong> the<br />
association of cervical cancer with unprotected sexual <strong>in</strong>tercourse with<br />
many partners.<br />
27 Adverse effects of chemotherapy<br />
Answers: M A J E G<br />
M<br />
A<br />
A 66-year-old woman treated with an alkylat<strong>in</strong>g agent for myeloma<br />
presents with severe haematuria.<br />
Haemorrhagic cystitis is caused by toxic metabolites of cyclophosphamide,<br />
e.g. acrole<strong>in</strong>. Mesna is a uroprotective agent that can be given<br />
orally or by <strong>in</strong>travenous <strong>in</strong>jection to react specifically with this metabolite<br />
<strong>in</strong> the ur<strong>in</strong>ary tract and prevent toxicity.<br />
A 34-year-old woman treated with a microtubular <strong>in</strong>hibitor for<br />
carc<strong>in</strong>oma of the breast develops a peripheral neuropathy.<br />
Microtubular <strong>in</strong>hibitors <strong>in</strong>clude the v<strong>in</strong>ca alkaloids, e.g. v<strong>in</strong>blast<strong>in</strong>e,<br />
v<strong>in</strong>crist<strong>in</strong>e, and the taxanes, e.g. paclitaxel, docetaxel. Tubul<strong>in</strong> is a<br />
prote<strong>in</strong> that is essential for formation of the sp<strong>in</strong>dle that separates the<br />
chromosomes dur<strong>in</strong>g mitosis.<br />
Neurotoxicity occurs as a result of <strong>in</strong>volvement of microtubules concerned<br />
with neuronal growth and axonal transport.